| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| W Waldhäus. Circadian rhythms of insulin needs and actions. Diabetes research and clinical practice. vol 6. issue 4. 1989-08-29. PMID:2666058. |
this basal mode of insulin secretion is subject to a multitude of endogenous control systems that act on the b-cell both in a stimulatory (e.g., beta-agonists, glucagon as well as glucose and amino acids) and an inhibitory fashion (e.g., alpha-agonists, somatostatin). |
1989-08-29 |
2023-08-11 |
human |
| F E Bauer, A Zintel, M J Kenny, D Calder, M A Ghatei, S R Bloo. Inhibitory effect of galanin on postprandial gastrointestinal motility and gut hormone release in humans. Gastroenterology. vol 97. issue 2. 1989-08-18. PMID:2472997. |
galanin potently suppressed the initial postprandial rise in plasma concentrations of glucose, insulin, peptide tyrosine tyrosine, neurotensin, enteroglucagon, pancreatic glucagon, somatostatin, and pancreatic polypeptide, but did not change gastric inhibitory polypeptide, motilin, peptide histidine methionine, and gastrin concentrations compared with control. |
1989-08-18 |
2023-08-11 |
human |
| K Nod. [Studies on developmental changes in rat pancreatic endocrine system during perinatal period]. Nihon Sanka Fujinka Gakkai zasshi. vol 41. issue 4. 1989-08-15. PMID:2568384. |
during the perinatal development of rats, pancreatic endocrine cells (b, a and d cells) were quantitated morphometrically and plasma insulin, glucagon and somatostatin were measured. |
1989-08-15 |
2023-08-11 |
rat |
| W J Krause, J H Cutts, J H Cutts, J Yamad. Immunohistochemical study of the developing endocrine pancreas of the opossum (Didelphis virginiana). Acta anatomica. vol 135. issue 1. 1989-08-14. PMID:2665414. |
cells immunoreactive for insulin, glucagon, somatostatin, bovine pancreatic polypeptide and 5-hydroxytryptamine are found in the pancreas of the newborn opossum and of all later stages examined. |
1989-08-14 |
2023-08-11 |
cattle |
| D H Wasserman, J A Spalding, D B Lacy, C A Colburn, R E Goldstein, A D Cherringto. Glucagon is a primary controller of hepatic glycogenolysis and gluconeogenesis during muscular work. The American journal of physiology. vol 257. issue 1 Pt 1. 1989-08-11. PMID:2665514. |
five dogs were studied during paired experiments in which pancreatic hormones were clamped at basal levels during a control period (using somatostatin and intraportal hormone replacement), then altered during exercise to stimulate the normal exercise-induced fall in insulin, while glucagon was 1) increased to mimic its normal exercise-induced rise (sg) and 2) maintained at a basal level (bg). |
1989-08-11 |
2023-08-11 |
dog |
| E Peiró, P Miralles, R A Silvestre, M L Villanueva, J Marc. Pancreastatin inhibits insulin secretion as induced by glucagon, vasoactive intestinal peptide, gastric inhibitory peptide, and 8-cholecystokinin in the perfused rat pancreas. Metabolism: clinical and experimental. vol 38. issue 7. 1989-08-10. PMID:2661967. |
to further explore the influence of pancreastatin on islet cell secretion, the effect of synthetic porcine pancreastatin (a 2-micrograms priming dose, followed by constant infusion at a concentration of 15.7 nmol/l) was studied on the insulin, glucagon, and somatostatin responses to 1 nmol/l vasoactive intestinal peptide (vip), 1 nmol/l gastric inhibitory peptide (gip), and 1 nmol/l 26 to 33 octapeptide form of cholecystokinin (8-cck). |
1989-08-10 |
2023-08-11 |
rat |
| E Peiró, P Miralles, R A Silvestre, M L Villanueva, J Marc. Pancreastatin inhibits insulin secretion as induced by glucagon, vasoactive intestinal peptide, gastric inhibitory peptide, and 8-cholecystokinin in the perfused rat pancreas. Metabolism: clinical and experimental. vol 38. issue 7. 1989-08-10. PMID:2661967. |
the effect of pancreastatin on the insulin and somatostatin secretion elicited by glucagon (20 nmol/l) was also examined. |
1989-08-10 |
2023-08-11 |
rat |
| E Peiró, P Miralles, R A Silvestre, M L Villanueva, J Marc. Pancreastatin inhibits insulin secretion as induced by glucagon, vasoactive intestinal peptide, gastric inhibitory peptide, and 8-cholecystokinin in the perfused rat pancreas. Metabolism: clinical and experimental. vol 38. issue 7. 1989-08-10. PMID:2661967. |
pancreastatin infusion consistently reduced the insulin responses to vip, gip, and 8-cck without modifying glucagon or somatostatin release. |
1989-08-10 |
2023-08-11 |
rat |
| E Peiró, P Miralles, R A Silvestre, M L Villanueva, J Marc. Pancreastatin inhibits insulin secretion as induced by glucagon, vasoactive intestinal peptide, gastric inhibitory peptide, and 8-cholecystokinin in the perfused rat pancreas. Metabolism: clinical and experimental. vol 38. issue 7. 1989-08-10. PMID:2661967. |
it also inhibited the insulin release but not the somatostatin output induced by glucagon. |
1989-08-10 |
2023-08-11 |
rat |
| H Ishii, K Miyazaki, A Funakoshi, H Nawata, K Konomi, A Jim. A case of multiple endocrine neoplasia (MEN) type 1; the immunohistochemical and ultrastructural studies of its tumors and the analysis of hormones in tumor extracts. Endocrinologia japonica. vol 36. issue 1. 1989-07-14. PMID:2567230. |
measurement of hormone contents and immunohistochemical studies of the pancreatic tumors showed that the tumors contained insulin, glucagon, somatostatin, and pancreatic polypeptide. |
1989-07-14 |
2023-08-11 |
Not clear |
| D Deville de Perière, D Hillaire-Buys, R Gross, R Puech, S Arancibi. Increases in concentrations of somatostatin- and insulin-like immunoreactivities in submandibular salivary gland of diabetic rats: effect of insulin treatment. Acta endocrinologica. vol 120. issue 6. 1989-07-11. PMID:2658456. |
chronic insulin treatment of diabetic rats reversed the increase in somatostatin, but had no effect on the increase in insulin-like immunoreactivity concentration. |
1989-07-11 |
2023-08-11 |
rat |
| D Deville de Perière, D Hillaire-Buys, R Gross, R Puech, S Arancibi. Increases in concentrations of somatostatin- and insulin-like immunoreactivities in submandibular salivary gland of diabetic rats: effect of insulin treatment. Acta endocrinologica. vol 120. issue 6. 1989-07-11. PMID:2658456. |
a negative correlation (r = 0.24, p less than 0.05) was found between the plasma insulin level and the somatostatin concentration of the submandibular glands. |
1989-07-11 |
2023-08-11 |
rat |
| J Verhaeghe, T L Peeters, M Vandeputte, W Rombauts, R Bouillon, F A Van Assch. Maternal and fetal endocrine pancreas in the spontaneously diabetic BB rat. Biology of the neonate. vol 55. issue 4-5. 1989-07-10. PMID:2566332. |
plasma insulin levels were decreased while plasma glucagon and somatostatin concentrations were normal. |
1989-07-10 |
2023-08-11 |
rat |
| M Beylot, C Chambrier, A Moneger, R Cohe. Effects of small variations in insulin and glucagon levels on plasma aminoacids concentrations. Diabete & metabolisme. vol 15. issue 1. 1989-07-10. PMID:2566520. |
to determine the effect in normal subjects of small variations of insulin and glucagon on plasma aminoacids concentrations we suppressed endocrine pancreas secretion with somatostatin and measured aminoacids levels during a sequential insulin infusion in the absence (control test, low glucagon level) or in the presence (normal glucagon concentration) of a replacement glucagon infusion. |
1989-07-10 |
2023-08-11 |
human |
| H Yasuda, S Suzuki, S Sawada, Y Kanasawa, K Yamaguchi, S Kume, P Y Cheng, T Katori, H Ok. Stimulative effects of TMB-8 and trifluoperazine on pancreatic hormone release. Diabetes research and clinical practice. vol 6. issue 3. 1989-07-07. PMID:2566459. |
tmb-8 and tfp stimulated insulin, glucagon, and somatostatin release in a dose-dependent manner at a low glucose concentration (2.5 mm). |
1989-07-07 |
2023-08-11 |
rat |
| H Yasuda, S Suzuki, S Sawada, Y Kanasawa, K Yamaguchi, S Kume, P Y Cheng, T Katori, H Ok. Stimulative effects of TMB-8 and trifluoperazine on pancreatic hormone release. Diabetes research and clinical practice. vol 6. issue 3. 1989-07-07. PMID:2566459. |
the addition of ne (10(-9) m) to the incubation medium increased insulin, glucagon, and somatostatin secretion by 20-30% over control levels (p less than 0.05). |
1989-07-07 |
2023-08-11 |
rat |
| M W Gunion, M J Rosenthal, K Tatemoto, J E Morle. Intracranial microinfusion of pancreastatin elevates blood glucose, free fatty acids, and corticosterone in rats. Brain research. vol 485. issue 2. 1989-07-07. PMID:2720411. |
pancreastatin, a novel peptide recently isolated from porcine pancreas, significantly inhibits insulin and somatostatin release and augments glucagon release from the isolated perfused rat pancreas. |
1989-07-07 |
2023-08-11 |
rat |
| J Drukker, E A Terwindt-Rouwenhorst, E L Wiertz-Hoessel. The synthesis of peptides in enteroendocrine cells developing in explanted presumptive endoderm. Acta histochemica. Supplementband. vol 36. 1989-07-07. PMID:3150567. |
the presence of gastrin, glucagon, cholecystokinin, vip, substance p, somatostatin, bombesin, motilin, secretin, pancreatic polypeptide, neurotensin and insulin was demonstrated. |
1989-07-07 |
2023-08-11 |
chicken |
| E Ferrannini, L Locatelli, E Jequier, J P Felbe. Differential effects of insulin and hyperglycemia on intracellular glucose disposition in humans. Metabolism: clinical and experimental. vol 38. issue 5. 1989-06-30. PMID:2657326. |
in all protocols, somatostatin was used to block endogenous insulin response. |
1989-06-30 |
2023-08-11 |
human |
| L Baschieri, A Antonelli, P del Guerra, A Fialdini, L Gasperin. Somatostatin effect in postprandial hypoglycemia. Metabolism: clinical and experimental. vol 38. issue 6. 1989-06-29. PMID:2566889. |
the effect of the administration of oral glucose with or without a simultaneous intravenous somatostatin infusion on blood glucose, immunoreactive insulin, c-peptide, and glucagon levels in seven patients with idiopathic postprandial hypoglycemia was studied. |
1989-06-29 |
2023-08-11 |
human |